Esperion Therapeutics
ESPR
#6143
Rank
HK$6.99 B
Marketcap
HK$29.49
Share price
-3.07%
Change (1 day)
-0.96%
Change (1 year)

Market capitalization of Esperion Therapeutics (ESPR)

Market cap: HK$6.99 Billion

As of December 2025 Esperion Therapeutics has a market cap of HK$6.99 Billion. This makes Esperion Therapeutics the world's 6143th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Esperion Therapeutics from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$6.99 B100.45%
2024HK$3.48 B31.34%
2023HK$2.65 B-25.96%
2022HK$3.58 B51.06%
2021HK$2.37 B-54.55%
2020HK$5.22 B-59.1%
2019HK$12.77 B32.16%
2018HK$9.66 B-28.3%
2017HK$13.47 B515.44%
2016HK$2.18 B-43.63%
2015HK$3.88 B-39.12%
2014HK$6.38 B290.41%
2013HK$1.63 B

End of Day market cap according to different sources

On Dec 9th, 2025 the market cap of Esperion Therapeutics was reported to be:

HK$7.04 Billion
by Nasdaq info icon info icon
HK$6.99 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Ultragenyx Pharmaceutical
RARE
HK$27.24 B 289.78%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$80.33 B 1,049.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$1.120 T 15,928.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
HK$571.14 B 8,069.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
HK$23.55 B 236.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
HK$3.70 B-47.02%๐Ÿ‡บ๐Ÿ‡ธ USA